SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001387131-21-004887
Filing Date
2021-04-23
Accepted
2021-04-23 17:02:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT tnxp-s3a_042021.htm S-3/A 187129
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 18382
3 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 15283
4 CONSENT OF EISNERAMPER LLP ex23-01.htm EX-23.01 3919
5 GRAPHIC tnxp-001.jpg GRAPHIC 10457
6 GRAPHIC ex5-01_img01.jpg GRAPHIC 6208
7 GRAPHIC ex5-02_img01.jpg GRAPHIC 7624
8 GRAPHIC ex5-02_img02.jpg GRAPHIC 12938
9 GRAPHIC ex5-02_img03.jpg GRAPHIC 5601
  Complete submission text file 0001387131-21-004887.txt   285470
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-254975 | Film No.: 21850555
SIC: 2834 Pharmaceutical Preparations